Advertisement

Current Psychiatry Reports

, Volume 11, Issue 5, pp 377–384 | Cite as

Management of opioid medications in patients with chronic pain and risk of substance misuse

  • Seddon R. Savage
Article

Abstract

When prescribed appropriately and used as prescribed, opioid medications can safely and effectively treat pain. Best practices with respect to their use in chronic non-cancer-related pain (CNCP) are evolving. Opioids may be subject to misuse for a variety of purposes, including self-medication, use for reward, compulsive use because of addiction, and diversion for profit. Individuals with chronic pain and co-occurring substance use, mental health disorders, and other conditions may be at increased risk for misuse of prescribed opioids. Interdisciplinary pain management, the use of universal precautions in all patients, and special attention to the structure of care in those at higher risk for opioid misuse may improve outcomes in opioid treatment of CNCP. This article discusses evolving research and clinical literature related to the care of individuals with CNCP at a higher risk for opioid misuse.

Keywords

Methadone Maintenance Treatment Chronic Pain Patient Opioid Treatment Opioid Medication Universal Precaution 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Lee L: Medication in the control of pain in terminal cancer. JAMA 1941, 116:216–220.Google Scholar
  2. 2.
    Quality improvement guidelines for the treatment of acute pain and cancer pain. American Pain Society Quality of Care Committee. JAMA 1995, 274:1874–1881.Google Scholar
  3. 3.
    Portenoy R: Chronic opioid therapy in nonmalignant pain. J Pain Sympton Manage 1990, 5:S46–S61.CrossRefGoogle Scholar
  4. 4.
    Ballantyne J, Shin N: Efficacy of opioids for chronic pain: a review of the evidence. Clin J Pain 2008, 24:469–478.PubMedCrossRefGoogle Scholar
  5. 5.
    Manchikanti L, Singh A: Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician 2008, 11:S63–S88.PubMedGoogle Scholar
  6. 6.
    Drug Abuse Warning Network: Emergency visits involving non medical use of selected pharmaceuticals. In The New DAWN Report, Issue 23, 2006. Available at http://dawninfo.samhsa.gov/files/TNDR/2006-07R/TNDR07EDVisitsNonMedicalUse.htm. Accessed August 27, 2009.
  7. 7.
    Substance Abuse and Mental Health Services Administration, Office of Applied Studies: Treatment Episode Data Set (TEDS). Available at http://www.wwwdasis.samhsa.gov/webt/newmapv1.htm. Accessed August 27, 2009.
  8. 8.
    Layne R, Pellegrino R, Lerfald N: Prescription opioids and overdose deaths. JAMA 2009, 301:1766–1767.PubMedCrossRefGoogle Scholar
  9. 9.
    Zacny JP, Lichtor SA: Nonmedical use of prescription opioids: motive and ubiquity issues. J Pain 2008, 9:473–486.PubMedCrossRefGoogle Scholar
  10. 10.
    Berrocoso E, Sanchez-Blazquez P, Garzon J, Mico J: Opiates as antidepressants. Curr Pharm Des 2009, 15:1612–1622.PubMedCrossRefGoogle Scholar
  11. 11.
    Schwartz A, Bradley R, Penza K, et al.: Pain medication use among patients with posttraumatic stress disorder. Psychosomatics 2006, 47:136–142.PubMedCrossRefGoogle Scholar
  12. 12.
    Koob G: Neurobiological substrates for the dark side of compulsivity in addiction. Neuropharmacology 2009, 56(Suppl 1):S18–S31.CrossRefGoogle Scholar
  13. 13.
    Ballantyne J, LaForge K: Opioid dependence and addiction during opioid treatment of chronic pain. Pain 2007, 129:235–255.PubMedCrossRefGoogle Scholar
  14. 14.
    McCabe SE, Boyd CJ, Teter CJ: Subtypes of nonmedical prescription drug misuse. Drug Alcohol Depend 2009, 102:63–70.PubMedCrossRefGoogle Scholar
  15. 15.
    Rollason V, Samer C, Piquet V, et al.: Pharmacogenetics of analgesics: towards individualization of prescription. Pharmacogenetics 2008, 9:905–933.Google Scholar
  16. 16.
    Dickenson AH, Suzuki R: Opioids in neuropathic pain: clues from animal studies. Eur J Pain 2005, 9:113–116.PubMedCrossRefGoogle Scholar
  17. 17.
    Chu LF, Angst MS, Clark D: Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin J Pain 2008, 24:479–496.PubMedCrossRefGoogle Scholar
  18. 18.
    Chou R, Fanciullo G, Fine P, et al.: Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009, 10:113–130.PubMedCrossRefGoogle Scholar
  19. 19.
    Silverman SL: Opioid induced hyperalgesia: clinical implications for the pain practitioner. Pain Physician 2009, 12:679–684.PubMedGoogle Scholar
  20. 20.
    Vadalouca A, Moka E, Argyra E, et al.: Opioid rotation in patients with cancer: a review of the current literature. J Opioid Manag 2008, 4:213–250.PubMedGoogle Scholar
  21. 21.
    Vorobeychik Y, Chen L, Bush M, Mao J: Improved opioid analgesic effect following opioid dose reduction. Pain Med 2008, 9:724–727.PubMedCrossRefGoogle Scholar
  22. 22.
    Kieffer B, Evans C: Opioid receptors: from binding sites to visible molecules in vivo. Neuropharmacology 2009, 56:205–212.PubMedCrossRefGoogle Scholar
  23. 23.
    Somogyi A, Barratt D, Coller J: Pharmacogenetics of opioids. Clin Pharmacol Ther 2007, 81:429–444.PubMedCrossRefGoogle Scholar
  24. 24.
    Webster L: Pharmacogenetics in pain management: the clinical need. Clin Lab Med 2008, 28:569–579.PubMedCrossRefGoogle Scholar
  25. 25.
    O’Brien CP, Volkow N, Li TK: What’s in a word? Addiction versus dependence in DSM V. Am J Psychiatry 2006, 163:764–765.PubMedCrossRefGoogle Scholar
  26. 26.
    Joranson DE, Gilson AM: Drug crime is a source of abused pain medications in the united states. J Pain Symptom Manage 2005, 30:299–301.PubMedCrossRefGoogle Scholar
  27. 27.
    Substance Abuse and Mental Health Services Administration: Results from the 2006 National Survey on Drug Use and Health: National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies; 2007.Google Scholar
  28. 28.
    Rayport M: Experience in the management of patients medically addicted to narcotics. JAMA 1954, 165:684–691.Google Scholar
  29. 29.
    Porter J, Jick H: Addiction rare in patients treated with narcotics. N Engl J Med 1980, 302:123.PubMedGoogle Scholar
  30. 30.
    Perry S, Heindrich G: Management of pain during debridement: a survey of U.S. burn units. Pain 1982, 13:12–14.CrossRefGoogle Scholar
  31. 31.
    Fishbain D, Cole B, Lewis J, et al.: What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidencebased review. Pain Med 2008, 9:444–459.PubMedCrossRefGoogle Scholar
  32. 32.
    Niikura K, Narita M, Narita M, et al.: Direct evidence for the involvement of endogenous beta-endorphin in the suppression of the morphine-induced rewarding effect under a neuropathic pain-like state. Neurosci Lett 2008, 435:257–262.PubMedCrossRefGoogle Scholar
  33. 33.
    Zacny JP, McKay MA, Toledano AY, et al.: The effects of cold-water immersion stressor on the reinforcing and subjective effects of fentanyl in healthy volunteers. Drug Alcohol Depend 1996, 42:133–142.PubMedCrossRefGoogle Scholar
  34. 34.
    Martins S, Keyes K, Storr C, et al.: Pathways between nonmedical opioid use/dependence and psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend 2009, 103:16–24.PubMedCrossRefGoogle Scholar
  35. 35.
    Dowling K, Storr C, Chilcoat H: Potential influences on initiation and persistence of extramedical prescription pain reliever use in the US population. Clin J Pain 2006, 22:776–783.PubMedCrossRefGoogle Scholar
  36. 36.
    Wilsey B, Fishman S, Tsodikov A, et al.: Psychological co-morbidities predicting prescription opioid abuse among patient in chronic pain presenting to the emergency department. Pain Med 2008, 9:1107–1117.PubMedCrossRefGoogle Scholar
  37. 37.
    Edlund MJ, Steffick D, Hudson T, et al.: Risk factors for clinically recognized opioid abuse and dependence among veterans using opioid for chronic non-cancer pain. Pain 2007, 129:355–362.PubMedCrossRefGoogle Scholar
  38. 38.
    Morasco B, Dobscha S: Prescription medication misuse and substance use disorder in VA primary care patients with chronic pain. Gen Hosp Psychiatry 2008, 30:93–99.PubMedCrossRefGoogle Scholar
  39. 39.
    Ives TJ: Predictors of opioid misuse in patients with chronic pain: a prospective cohort study. BMC Health Serv Res 2006, 6:46.PubMedCrossRefGoogle Scholar
  40. 40.
    Meghani SH, Wiedemer NL, Becker WC, et al.: Predictors of resolution of aberrant drug behavior in chronic pain patients treated in a structured opioid risk management program. Pain Med 2009 Jun 11 (Epub ahead of print).Google Scholar
  41. 41.
    Bieber C, Fernandez K, Borsook D, et al.: Retrospective accounts of initial subjective effects of opioid in patients treated for pain who do or do not develop opioid addiction: a pilot case-control study. Exp Clin Psychopharmacol 2008, 16:429–434.PubMedCrossRefGoogle Scholar
  42. 42.
    Wasan AD, Butler SF, Budman SH, et al.: Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients? Clin J Pain 2009, 25:193–198.PubMedCrossRefGoogle Scholar
  43. 43.
    Turk D, Swanson K, Gatchel R: Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis. Clin J Pain 2008, 24:497–508.PubMedCrossRefGoogle Scholar
  44. 44.
    Chou R, Fanciullo G, Fine P, et al.: Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 2009, 10:131–146.PubMedCrossRefGoogle Scholar
  45. 45.
    Utah Department of Health: Utah clinical guidelines on prescribing opioids. Available at http://www.health.utah.gov/prescription/pdf/Utah_guidelines_pdfs.pdf. Accessed August 12, 2009.
  46. 46.
    Butler S, Fernandez K, Benoit C, et al.: Validation of the revised screener and opioid assessment for patients with pain (SOAPP-R). J Pain 2008, 9:360–372.PubMedCrossRefGoogle Scholar
  47. 47.
    Banta-Green C, Merrill J, Doyle S, et al.: Measurement of opioid problems among chronic pain patients in a general medical population. Drug Alcohol Depend 2009 May 25 (Epub ahead of print).Google Scholar
  48. 48.
    Butler SF, Budman SH, Fernandez KC, et al.: Development and validation of the current opioid misuse measure. Pain 2007, 130:144–156.PubMedCrossRefGoogle Scholar
  49. 49.
    Holmes C, Gatchel R, Adams L, et al.: An opioid screening instrument: long-term evaluation of the utility of the pain medication questionnaire. Pain Pract 2006, 6:74–88.PubMedGoogle Scholar
  50. 50.
    Wu SM, Compton P, Bolus R, et al.: The addiction behaviors checklist: validation of a new clinician-based measure of inappropriate opioid use in chronic pain. J Pain Symptom Manage 2006, 32:342–351.PubMedCrossRefGoogle Scholar
  51. 51.
    Wasan AD, Butler SF, Budman SH, et al.: Psychiatric history and psychologic adjustment as risk factors for aberrant drug-related behavior among patients with chronic pain. Clin J Pain 2007, 23:307–315.PubMedCrossRefGoogle Scholar
  52. 52.
    Fleming M, Davis J, Passik S: Reported lifetime aberrant drug-taking behaviors are predictive of current substance use and mental health problems in primary care patients. Pain Med 2008, 9:1098–1106.PubMedCrossRefGoogle Scholar
  53. 53.
    Gourlay DL, Heit HA, Almahrezi A: Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Med 2005, 6:107–112.PubMedCrossRefGoogle Scholar
  54. 54.
    Nafziger AN, Bertino JS Jr: Utility and application of urine drug testing in chronic pain management with opioids. Clin J Pain 2009, 25:73–79.PubMedCrossRefGoogle Scholar
  55. 55.
    Passik SD: Issues in long-term opioid therapy: unmet needs, risks, and solutions. Mayo Clin Proc 2009, 84:593–601.PubMedCrossRefGoogle Scholar
  56. 56.
    Blinderman CD, Sekine R, Zhang B, et al.: Methadone as an analgesic for patients with chronic pain in methadone maintenance treatment programs. J Opioid Manag 2009, 5:107–114.PubMedGoogle Scholar
  57. 57.
    Rosenblum A, Marsch LA, Joseph H, Portenoy RK: Opioids and the treatment of chronic pain: controversies, current status, and future directions. Exp Clin Psychopharmacol 2008, 16:405–416.PubMedCrossRefGoogle Scholar
  58. 58.
    Federation of State Medical Boards: Model policy for the use of controlled substances for the treatment of pain. Available at http://fsmb.org/pdf/2004_grpol_Controlled_Substances.pdf2004. Accessed August 27, 2009.
  59. 59.
    Fishman F: Responsible Opioid Prescribing: A Physician’s Guide. Washington, DC: Federation of State Medical Boards and Waterford Life Sciences; 2007.Google Scholar
  60. 60.
    Chou R, Ballantyne JC, Fanciullo G, et al.: Research gaps on use of opioids for noncancer pain: findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 2009, 10:147–159.PubMedCrossRefGoogle Scholar
  61. 61.
    Fishman S, Webster L: Unintended harm from opioid prescribing guidelines. Pain Med 2008, 10:285–286.Google Scholar

Copyright information

© Current Medicine Group, LLC 2009

Authors and Affiliations

  1. 1.Dartmouth CollegeHanoverUSA

Personalised recommendations